- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- hetero-oligomer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 26 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 5 residues within 4Å:- Chain C: A.25, G.26, E.27, R.28
- Chain E: Q.30
Ligand excluded by PLIPSO4.3: 5 residues within 4Å:- Chain A: R.574, A.696, A.697, T.722
- Chain C: R.176
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: K.446, I.447
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain B: N.13, N.14, P.15
Ligand excluded by PLIPSO4.6: 5 residues within 4Å:- Chain A: T.709
- Chain D: H.24, N.68, A.84, G.85
Ligand excluded by PLIPSO4.7: 6 residues within 4Å:- Chain A: R.487, S.513
- Chain B: H.7, K.171, H.174, K.277
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: N.651, G.652, S.847, L.849
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain A: H.870, R.929, N.930
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: Q.217, R.219
- Chain C: V.199
Ligand excluded by PLIPSO4.11: 6 residues within 4Å:- Chain A: S.1, K.285, L.349, S.350, A.371, D.372
Ligand excluded by PLIPSO4.12: 5 residues within 4Å:- Chain A: Q.489, D.493, Y.511, T.512
- Chain B: H.7
Ligand excluded by PLIPSO4.13: 6 residues within 4Å:- Chain C: R.119, T.153, P.160
- Chain D: S.60, G.62, R.64
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain A: S.7, A.8, R.18
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain A: Q.30
- Chain G: A.25, G.26, E.27, R.28
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain E: R.574, A.696, A.697, T.722
- Chain G: R.176
Ligand excluded by PLIPSO4.23: 2 residues within 4Å:- Chain E: K.446, I.447
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain F: N.13, N.14, P.15
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain E: T.709
- Chain H: H.24, N.68, A.84, G.85
Ligand excluded by PLIPSO4.26: 6 residues within 4Å:- Chain E: R.487, S.513
- Chain F: H.7, K.171, H.174, K.277
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain E: N.651, G.652, S.847, L.849
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain E: H.870, R.929, N.930
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain E: Q.217, R.219
- Chain G: V.199
Ligand excluded by PLIPSO4.30: 6 residues within 4Å:- Chain E: S.1, K.285, L.349, S.350, A.371, D.372
Ligand excluded by PLIPSO4.31: 5 residues within 4Å:- Chain E: Q.489, D.493, Y.511, T.512
- Chain F: H.7
Ligand excluded by PLIPSO4.32: 6 residues within 4Å:- Chain G: R.119, T.153, P.160
- Chain H: S.60, G.62, R.64
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain E: S.7, A.8, R.18
Ligand excluded by PLIP- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.15: 38 residues within 4Å:- Chain B: V.26, G.27, G.28, G.29, G.30, H.31, L.51, E.52, K.53, G.59, N.60, M.61, R.63, N.64, T.65, T.66, I.67, C.194, E.195, V.196, A.224, G.225, A.226, H.228, L.232, L.247, Q.248, A.249, G.326, V.328, W.352, G.353, T.354, G.355, G.356, F.357, K.358
- Ligands: DMG.19
32 PLIP interactions:32 interactions with chain B- Hydrophobic interactions: B:L.247, B:L.247, B:L.247, B:A.249
- Hydrogen bonds: B:G.30, B:H.31, B:K.53, B:G.59, B:N.60, B:N.60, B:M.61, B:N.64, B:T.65, B:I.67, B:I.67, B:V.196, B:V.196, B:G.353, B:G.356, B:F.357, B:K.358, B:K.358
- Water bridges: B:G.28, B:G.29, B:G.32, B:E.52, B:K.53, B:K.53, B:G.58, B:N.60
- Salt bridges: B:H.31
- pi-Cation interactions: B:K.53
FAD.34: 38 residues within 4Å:- Chain F: V.26, G.27, G.28, G.29, G.30, H.31, L.51, E.52, K.53, G.59, N.60, M.61, R.63, N.64, T.65, T.66, I.67, C.194, E.195, V.196, A.224, G.225, A.226, H.228, L.232, L.247, Q.248, A.249, G.326, V.328, W.352, G.353, T.354, G.355, G.356, F.357, K.358
- Ligands: DMG.38
34 PLIP interactions:34 interactions with chain F- Hydrophobic interactions: F:L.247, F:L.247, F:L.247, F:A.249
- Hydrogen bonds: F:G.30, F:H.31, F:K.53, F:G.59, F:N.60, F:N.60, F:M.61, F:N.64, F:T.65, F:T.65, F:I.67, F:I.67, F:V.196, F:V.196, F:G.353, F:G.356, F:F.357, F:K.358, F:K.358
- Water bridges: F:G.28, F:G.29, F:G.32, F:E.52, F:K.53, F:K.53, F:G.58, F:N.60, F:E.195
- Salt bridges: F:H.31
- pi-Cation interactions: F:K.53
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.16: 28 residues within 4Å:- Chain A: V.133, G.134, A.135, G.136, P.137, A.138, L.156, D.157, E.158, R.159, G.164, T.165, T.202, T.203, V.204, A.247, T.248, A.249, N.292, S.294, F.380, L.386, G.416, A.417, L.422, D.423, T.424, Y.553
28 PLIP interactions:28 interactions with chain A- Hydrophobic interactions: A:F.380, A:F.380, A:L.422
- Hydrogen bonds: A:A.135, A:A.138, A:E.158, A:E.158, A:R.159, A:R.159, A:T.165, A:T.165, A:T.165, A:V.204, A:V.204, A:N.292, A:A.417, A:D.423, A:T.424
- Water bridges: A:G.136, A:G.136, A:D.157, A:G.164, A:A.250, A:A.250, A:L.418, A:L.418, A:L.422, A:T.424
NAD.35: 28 residues within 4Å:- Chain E: V.133, G.134, A.135, G.136, P.137, A.138, L.156, D.157, E.158, R.159, G.164, T.165, T.202, T.203, V.204, A.247, T.248, A.249, N.292, S.294, F.380, L.386, G.416, A.417, L.422, D.423, T.424, Y.553
28 PLIP interactions:28 interactions with chain E- Hydrophobic interactions: E:F.380, E:F.380, E:L.422
- Hydrogen bonds: E:A.135, E:A.138, E:D.157, E:E.158, E:R.159, E:R.159, E:T.165, E:T.165, E:T.165, E:V.204, E:V.204, E:N.292, E:A.417, E:D.423
- Water bridges: E:G.136, E:G.136, E:D.157, E:G.164, E:A.250, E:A.250, E:L.418, E:L.418, E:L.422, E:T.424, E:Y.553
- 2 x FON: FOLINIC ACID(Non-covalent)
FON.17: 14 residues within 4Å:- Chain A: L.631, Y.663, D.676, G.677, V.678, H.690, T.691, I.774, S.775, F.776, E.783, K.822, F.824, W.844
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:Y.663, A:V.678
- Hydrogen bonds: A:H.690, A:T.691, A:K.822
- Water bridges: A:Y.663
- Salt bridges: A:E.783, A:K.822
FON.36: 14 residues within 4Å:- Chain E: L.631, Y.663, D.676, G.677, V.678, H.690, T.691, I.774, S.775, F.776, E.783, K.822, F.824, W.844
9 PLIP interactions:9 interactions with chain E- Hydrophobic interactions: E:Y.663, E:V.678
- Hydrogen bonds: E:H.690, E:T.691, E:K.822
- Water bridges: E:Y.663, E:E.783
- Salt bridges: E:E.783, E:K.822
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
FMN.18: 16 residues within 4Å:- Chain A: K.509, R.510, T.516, Q.520, T.548, R.550
- Chain B: A.62, R.63, N.64, T.66, H.172, V.251, K.277, E.279, R.322, W.324
21 PLIP interactions:12 interactions with chain B, 9 interactions with chain A- Hydrophobic interactions: B:T.66, B:V.251, B:W.324, B:W.324
- Hydrogen bonds: B:K.277, B:R.322, B:R.322, B:R.322, A:K.509, A:R.510, A:T.516, A:Q.520, A:T.548
- Water bridges: B:R.63, B:R.63, A:T.548, A:T.548
- Salt bridges: B:R.63, B:R.322, A:K.509, A:R.550
FMN.37: 16 residues within 4Å:- Chain E: K.509, R.510, T.516, Q.520, T.548, R.550
- Chain F: A.62, R.63, N.64, T.66, H.172, V.251, K.277, E.279, R.322, W.324
22 PLIP interactions:9 interactions with chain E, 13 interactions with chain F- Hydrogen bonds: E:K.509, E:R.510, E:T.516, E:Q.520, F:K.277, F:E.279, F:R.322, F:R.322, F:R.322
- Water bridges: E:T.516, E:T.548, E:T.548, F:R.63, F:R.63
- Salt bridges: E:K.509, E:R.550, F:R.63, F:R.322
- Hydrophobic interactions: F:T.66, F:V.251, F:W.324, F:W.324
- 2 x DMG: N,N-DIMETHYLGLYCINE(Non-covalent)
DMG.19: 10 residues within 4Å:- Chain B: T.65, I.67, R.69, Y.72, M.264, T.354, G.355, K.358, A.401
- Ligands: FAD.15
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:T.65
- Water bridges: B:K.358, B:A.401
- Salt bridges: B:R.69, B:K.358
DMG.38: 10 residues within 4Å:- Chain F: T.65, I.67, R.69, Y.72, M.264, T.354, G.355, K.358, A.401
- Ligands: FAD.34
5 PLIP interactions:5 interactions with chain F- Hydrogen bonds: F:Y.72
- Water bridges: F:K.358, F:A.401
- Salt bridges: F:R.69, F:K.358
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ida, K. et al., Crystal structure of heterotetrameric sarcosine oxidase from Corynebacterium sp. U-96. BIOCHEM.BIOPHYS.RES.COMMUN. (2005)
- Release Date
- 2005-07-05
- Peptides
- Sarcosine oxidase alpha subunit: AE
Sarcosine oxidase beta subunit: BF
Sarcosine oxidase gamma subunit: CG
Sarcosine oxidase delta subunit: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AB
BF
BC
CG
CD
DH
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- hetero-oligomer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 26 x SO4: SULFATE ION(Non-functional Binders)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 2 x FON: FOLINIC ACID(Non-covalent)
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 2 x DMG: N,N-DIMETHYLGLYCINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ida, K. et al., Crystal structure of heterotetrameric sarcosine oxidase from Corynebacterium sp. U-96. BIOCHEM.BIOPHYS.RES.COMMUN. (2005)
- Release Date
- 2005-07-05
- Peptides
- Sarcosine oxidase alpha subunit: AE
Sarcosine oxidase beta subunit: BF
Sarcosine oxidase gamma subunit: CG
Sarcosine oxidase delta subunit: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AB
BF
BC
CG
CD
DH
D